Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DULOXETINE Cause Therapeutic product effect incomplete? 284 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 284 reports of Therapeutic product effect incomplete have been filed in association with DULOXETINE (Duloxetine Hydrochloride). This represents 0.5% of all adverse event reports for DULOXETINE.

284
Reports of Therapeutic product effect incomplete with DULOXETINE
0.5%
of all DULOXETINE reports
2
Deaths
38
Hospitalizations

How Dangerous Is Therapeutic product effect incomplete From DULOXETINE?

Of the 284 reports, 2 (0.7%) resulted in death, 38 (13.4%) required hospitalization, and 13 (4.6%) were considered life-threatening.

Is Therapeutic product effect incomplete Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DULOXETINE. However, 284 reports have been filed with the FAERS database.

What Other Side Effects Does DULOXETINE Cause?

Nausea (7,355) Dizziness (6,983) Drug withdrawal syndrome (6,503) Headache (5,541) Fatigue (5,309) Insomnia (5,270) Anxiety (4,973) Paraesthesia (4,854) Drug ineffective (4,829) Hyperhidrosis (4,101)

What Other Drugs Cause Therapeutic product effect incomplete?

ALBUTEROL (8,496) ADALIMUMAB (6,986) PREDNISONE (6,709) METHOTREXATE (6,037) TOFACITINIB (4,914) SECUKINUMAB (4,661) BUDESONIDE\FORMOTEROL (4,392) TIOTROPIUM (4,327) MEPOLIZUMAB (4,106) ETANERCEPT (3,961)

Which DULOXETINE Alternatives Have Lower Therapeutic product effect incomplete Risk?

DULOXETINE vs DUPILUMAB DULOXETINE vs DURAGESIC DULOXETINE vs DUROGESIC DULOXETINE vs DUROTEP MT DULOXETINE vs DURVALUMAB

Related Pages

DULOXETINE Full Profile All Therapeutic product effect incomplete Reports All Drugs Causing Therapeutic product effect incomplete DULOXETINE Demographics